Výsledky vyhledávání - "Florence Turcry"

Survival, cost and added therapeutic benefit of drugs granted early access through the French temporary authorization for use program in solid tumors from 2009 to 2019

Autor: Fiona Y.‐V. Pham, Emmanuelle Jacquet, Amina Taleb, Adrien Monard, Ghania Kerouani‐Lafaye, Florence Turcry, Liora Brunel, Françoise Grudé, Isabelle Yoldjian, Isabelle Sainte‐Marie, Lotfi Boudali, Jean‐Yves Blay, Nicolas Albin

Publikováno v: International journal of cancer. 151(8)

Decisions on market authorization (MA) and reimbursement have different durations across countries because of health technology assessment (HTA) procedures and negotiations between manufacturers and national authorities. To overcome this delay, Franc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f982c483de90a7b1832d0f5904b3bab8
https://pubmed.ncbi.nlm.nih.gov/35603979

Zobrazit plný text záznamu

Access to innovation through the national early access program and clinical trials for patients with malignant melanoma

Autor: Claire, Christen, Laetitia, Belgodère, Bernard, Guillot, Céline, Jumeau, Annie, Lorence, Ghania, Kerouani-Lafaye, Liora, Brunel, Florence, Turcry, Adrien, Monard, Francoise, Grudé, Gaëlle, Guyader, Lotfi, Boudali, Nicolas, Albin

Publikováno v: Cancer. 127(13)

The arrival of immunotherapies and targeted therapies challenged the authorities to make them available as soon as possible. France has effective tools, such as clinical trials (CTs) and a national early access program (temporary authorizations for u

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::92e80cdab7e9bebf06ee70ee955cf8e3
https://pubmed.ncbi.nlm.nih.gov/33788953

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání